Health Services Stocks On The Rise With Help From 5 Stocks

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 70 points (0.5%) at 14,846 as of Wednesday, Aug. 28, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,865 issues advancing vs. 1,062 declining with 104 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is up 0.6%. Top gainers within the industry include Opko Health ( OPK), up 2.5%, Mettler-Toledo International ( MTD), up 0.8% and C.R. Bard ( BCR), up 0.4%. On the negative front, top decliners within the industry include Grifols ( GRFS), down 0.7%, and Fresenius Medical Care AG & Co. KGaA ( FMS), down 0.5%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. CareFusion ( CFN) is one of the companies pushing the Health Services industry higher today. As of noon trading, CareFusion is up $0.15 (0.4%) to $35.24 on light volume. Thus far, 584,873 shares of CareFusion exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $35.01-$35.48 after having opened the day at $35.11 as compared to the previous trading day's close of $35.09.

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, respiratory care, and surveillance and analytics. CareFusion has a market cap of $7.6 billion and is part of the health care sector. Shares are up 22.8% year to date as of the close of trading on Tuesday. Currently there are 6 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Becton Dickinson ( BDX) is up $0.42 (0.4%) to $97.67 on light volume. Thus far, 182,018 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 903,400 shares. The stock has ranged in price between $97.17-$97.98 after having opened the day at $97.54 as compared to the previous trading day's close of $97.25.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $19.2 billion and is part of the health care sector. Shares are up 24.4% year to date as of the close of trading on Tuesday. Currently there are 4 analysts that rate Becton Dickinson a buy, 4 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Becton Dickinson Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, St Jude Medical ( STJ) is up $0.09 (0.2%) to $50.54 on light volume. Thus far, 284,705 shares of St Jude Medical exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $50.14-$50.62 after having opened the day at $50.49 as compared to the previous trading day's close of $50.45.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $15.0 billion and is part of the health care sector. Shares are up 39.7% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate St Jude Medical a buy, 2 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full St Jude Medical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Boston Scientific ( BSX) is up $0.04 (0.4%) to $10.74 on light volume. Thus far, 4.6 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 16.0 million shares. The stock has ranged in price between $10.67-$10.84 after having opened the day at $10.69 as compared to the previous trading day's close of $10.70.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $15.1 billion and is part of the health care sector. Shares are up 86.7% year to date as of the close of trading on Tuesday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance, expanding profit margins, impressive record of earnings per share growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Intuitive Surgical ( ISRG) is up $2.07 (0.5%) to $388.29 on average volume. Thus far, 321,643 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 573,300 shares. The stock has ranged in price between $385.42-$389.44 after having opened the day at $387.14 as compared to the previous trading day's close of $386.22.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $15.6 billion and is part of the health care sector. Shares are down 20.1% year to date as of the close of trading on Tuesday. Currently there are 9 analysts that rate Intuitive Surgical a buy, 2 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Intuitive Surgical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Asia Markets Fall on Latest Tariff Threats From Trump

Asia Markets Fall on Latest Tariff Threats From Trump

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries